WallStreetZenWallStreetZen

NASDAQ: PHVS
Pharvaris Nv Stock Forecast, Predictions & Price Target

Analyst price target for PHVS

Based on 4 analysts offering 12 month price targets for Pharvaris Nv.
Min Forecast
$11.00-52.65%
Avg Forecast
$29.75+28.07%
Max Forecast
$49.00+110.93%

Should I buy or sell PHVS stock?

Based on 4 analysts offering ratings for Pharvaris Nv.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
1 analysts 25%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PHVS stock forecasts and price targets.

PHVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-14
lockedlocked$00.00+00.00%2023-12-07
lockedlocked$00.00+00.00%2023-12-07
lockedlocked$00.00+00.00%2023-11-03

1 of 1

Forecast return on equity

Is PHVS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.53%

Forecast return on assets

Is PHVS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PHVS revenue forecast

What is PHVS's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$9.7M
Avg 2 year Forecast
$142.2M
Avg 3 year Forecast
$395.9M

PHVS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PHVS$23.23$29.75+28.07%Buy
RGNX$21.36$30.25+41.62%Buy
HLVX$19.75$30.67+55.28%Strong Buy
CABA$21.97$32.57+48.25%Strong Buy
INVA$15.26N/AN/A

Pharvaris Nv Stock Forecast FAQ

Is Pharvaris Nv Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: PHVS) stock is to Buy PHVS stock.

Out of 4 analysts, 1 (25%) are recommending PHVS as a Strong Buy, 2 (50%) are recommending PHVS as a Buy, 0 (0%) are recommending PHVS as a Hold, 1 (25%) are recommending PHVS as a Sell, and 0 (0%) are recommending PHVS as a Strong Sell.

If you're new to stock investing, here's how to buy Pharvaris Nv stock.

What is PHVS's revenue growth forecast for 2026-2028?

(NASDAQ: PHVS) Pharvaris Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Pharvaris Nv's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast PHVS's revenue for 2026 to be $398,771,158, with the lowest PHVS revenue forecast at $119,672,331, and the highest PHVS revenue forecast at $677,869,985. On average, 2 Wall Street analysts forecast PHVS's revenue for 2027 to be $5,829,476,948, with the lowest PHVS revenue forecast at $3,755,743,977, and the highest PHVS revenue forecast at $7,903,209,920.

In 2028, PHVS is forecast to generate $16,225,518,900 in revenue, with the lowest revenue forecast at $12,026,659,429 and the highest revenue forecast at $20,424,419,355.

What is PHVS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PHVS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PHVS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year PHVS price target, the average PHVS price target is $29.75, with the highest PHVS stock price forecast at $49.00 and the lowest PHVS stock price forecast at $11.00.

On average, Wall Street analysts predict that Pharvaris Nv's share price could reach $29.75 by Feb 14, 2025. The average Pharvaris Nv stock price prediction forecasts a potential upside of 28.07% from the current PHVS share price of $23.23.

What is PHVS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PHVS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.